Thomas King

Mr. Thomas B. King is a President & Director at Satsuma Pharmaceuticals, Inc. and an Executive Chairman at Concentric Analgesics, Inc. He is on the Board of Directors at Satsuma Pharmaceuticals, Inc. and Faraday Pharmaceuticals, Inc. Mr. King was previously employed as an Independent Director by TFF Pharmaceuticals, Inc., a Chairman by Achieve Life Sciences, Inc., a Chairman by Kinaset Therapeutics, Inc., an Independent Director by VIVUS, Inc., a President, Chief Executive Officer, CFO & CAO by Alexza Pharmaceuticals, Inc., a President, Chief Executive Officer & Director by Cognetix, Inc., and a President & Chief Executive Officer by Anesta Corp.
He also served on the board at Achaogen, Inc., Faraday Pharmaceuticals, Inc. (Washington), Orphan Medical, Inc. and Symphony Allegro, Inc. He received his undergraduate degree from McPherson College and an MBA from Kansas University School of Business.